 | • レポートコード：GIR-105X16317 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ピルフェニドンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ピルフェニドンの種類別市場規模（錠剤、カプセル、その他）、用途別市場規模（軽度特発性肺線維症、中等度特発性肺線維症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ピルフェニドンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Genentech (Roche)、Shionogi、GNI Group、Beijing Continent、Cipla、Lupin Ltd、Zydus Cadila、Glenmark Pharmaceuticals、Koye Pharmaceuticals、MSN Laboratories、Wockhardt、Incepta Pharmaceuticals、Unimed Unihealth ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：錠剤、カプセル、その他 ・用途別分析2016年-2026年：軽度特発性肺線維症、中等度特発性肺線維症、その他 ・ピルフェニドンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ピルフェニドンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ピルフェニドンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ピルフェニドンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ピルフェニドンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pirfenidone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pirfenidone size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Pirfenidone market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pirfenidone market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablet
Capsule
Other
Market segment by Application can be divided into
Mild Idiopathic Pulmonary Fibrosis
Moderate Idiopathic Pulmonary Fibrosis
Other
The key market players for global Pirfenidone market are listed below:
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
Wockhardt
Incepta Pharmaceuticals
Unimed Unihealth
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Pirfenidone Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pirfenidone Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Pirfenidone Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Mild Idiopathic Pulmonary Fibrosis
1.3.3 Moderate Idiopathic Pulmonary Fibrosis
1.3.4 Other
1.4 Global Pirfenidone Market Size & Forecast
1.4.1 Global Pirfenidone Sales in Value (2016-2026))
1.4.2 Global Pirfenidone Sales in Volume (2016-2026)
1.4.3 Global Pirfenidone Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Pirfenidone Production Capacity Analysis
1.5.1 Global Pirfenidone Total Production Capacity (2016-2026)
1.5.2 Global Pirfenidone Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pirfenidone Market Drivers
1.6.2 Pirfenidone Market Restraints
1.6.3 Pirfenidone Trends Analysis
2 Manufacturers Profiles
2.1 Genentech (Roche)
2.1.1 Genentech (Roche) Details
2.1.2 Genentech (Roche) Major Business
2.1.3 Genentech (Roche) Pirfenidone Product and Services
2.1.4 Genentech (Roche) Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Shionogi
2.2.1 Shionogi Details
2.2.2 Shionogi Major Business
2.2.3 Shionogi Pirfenidone Product and Services
2.2.4 Shionogi Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 GNI Group
2.3.1 GNI Group Details
2.3.2 GNI Group Major Business
2.3.3 GNI Group Pirfenidone Product and Services
2.3.4 GNI Group Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Beijing Continent
2.4.1 Beijing Continent Details
2.4.2 Beijing Continent Major Business
2.4.3 Beijing Continent Pirfenidone Product and Services
2.4.4 Beijing Continent Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Cipla
2.5.1 Cipla Details
2.5.2 Cipla Major Business
2.5.3 Cipla Pirfenidone Product and Services
2.5.4 Cipla Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Lupin Ltd
2.6.1 Lupin Ltd Details
2.6.2 Lupin Ltd Major Business
2.6.3 Lupin Ltd Pirfenidone Product and Services
2.6.4 Lupin Ltd Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Zydus Cadila
2.7.1 Zydus Cadila Details
2.7.2 Zydus Cadila Major Business
2.7.3 Zydus Cadila Pirfenidone Product and Services
2.7.4 Zydus Cadila Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Glenmark Pharmaceuticals
2.8.1 Glenmark Pharmaceuticals Details
2.8.2 Glenmark Pharmaceuticals Major Business
2.8.3 Glenmark Pharmaceuticals Pirfenidone Product and Services
2.8.4 Glenmark Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Koye Pharmaceuticals
2.9.1 Koye Pharmaceuticals Details
2.9.2 Koye Pharmaceuticals Major Business
2.9.3 Koye Pharmaceuticals Pirfenidone Product and Services
2.9.4 Koye Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 MSN Laboratories
2.10.1 MSN Laboratories Details
2.10.2 MSN Laboratories Major Business
2.10.3 MSN Laboratories Pirfenidone Product and Services
2.10.4 MSN Laboratories Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Wockhardt
2.11.1 Wockhardt Details
2.11.2 Wockhardt Major Business
2.11.3 Wockhardt Pirfenidone Product and Services
2.11.4 Wockhardt Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Incepta Pharmaceuticals
2.12.1 Incepta Pharmaceuticals Details
2.12.2 Incepta Pharmaceuticals Major Business
2.12.3 Incepta Pharmaceuticals Pirfenidone Product and Services
2.12.4 Incepta Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Unimed Unihealth
2.13.1 Unimed Unihealth Details
2.13.2 Unimed Unihealth Major Business
2.13.3 Unimed Unihealth Pirfenidone Product and Services
2.13.4 Unimed Unihealth Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Pirfenidone Sales by Manufacturer
3.1 Global Pirfenidone Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pirfenidone Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pirfenidone
3.4 Market Concentration Rate
3.4.1 Top 3 Pirfenidone Manufacturer Market Share
3.4.2 Top 6 Pirfenidone Manufacturer Market Share
3.5 Global Pirfenidone Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pirfenidone Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pirfenidone Market Size by Region
4.1.1 Global Pirfenidone Sales in Volume by Region (2016-2026)
4.1.2 Global Pirfenidone Revenue by Region (2016-2026)
4.2 North America Pirfenidone Revenue (2016-2026)
4.3 Europe Pirfenidone Revenue (2016-2026)
4.4 Asia-Pacific Pirfenidone Revenue (2016-2026)
4.5 South America Pirfenidone Revenue (2016-2026)
4.6 Middle East and Africa Pirfenidone Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pirfenidone Sales in Volume by Type (2016-2026)
5.2 Global Pirfenidone Revenue by Type (2016-2026)
5.3 Global Pirfenidone Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pirfenidone Sales in Volume by Application (2016-2026)
6.2 Global Pirfenidone Revenue by Application (2016-2026)
6.3 Global Pirfenidone Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pirfenidone Sales by Type (2016-2026)
7.2 North America Pirfenidone Sales by Application (2016-2026)
7.3 North America Pirfenidone Market Size by Country
7.3.1 North America Pirfenidone Sales in Volume by Country (2016-2026)
7.3.2 North America Pirfenidone Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pirfenidone Sales by Type (2016-2026)
8.2 Europe Pirfenidone Sales by Application (2016-2026)
8.3 Europe Pirfenidone Market Size by Country
8.3.1 Europe Pirfenidone Sales in Volume by Country (2016-2026)
8.3.2 Europe Pirfenidone Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pirfenidone Sales by Type (2016-2026)
9.2 Asia-Pacific Pirfenidone Sales by Application (2016-2026)
9.3 Asia-Pacific Pirfenidone Market Size by Region
9.3.1 Asia-Pacific Pirfenidone Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pirfenidone Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pirfenidone Sales by Type (2016-2026)
10.2 South America Pirfenidone Sales by Application (2016-2026)
10.3 South America Pirfenidone Market Size by Country
10.3.1 South America Pirfenidone Sales in Volume by Country (2016-2026)
10.3.2 South America Pirfenidone Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pirfenidone Sales by Type (2016-2026)
11.2 Middle East & Africa Pirfenidone Sales by Application (2016-2026)
11.3 Middle East & Africa Pirfenidone Market Size by Country
11.3.1 Middle East & Africa Pirfenidone Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pirfenidone Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pirfenidone Typical Distributors
12.3 Pirfenidone Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Pirfenidone Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pirfenidone Revenue by Application, (USD Million), 2021-2026
Table 3. Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table 4. Genentech (Roche) Major Business
Table 5. Genentech (Roche) Pirfenidone Product and Services
Table 6. Genentech (Roche) Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Shionogi Basic Information, Manufacturing Base and Competitors
Table 8. Shionogi Major Business
Table 9. Shionogi Pirfenidone Product and Services
Table 10. Shionogi Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GNI Group Basic Information, Manufacturing Base and Competitors
Table 12. GNI Group Major Business
Table 13. GNI Group Pirfenidone Product and Services
Table 14. GNI Group Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Beijing Continent Basic Information, Manufacturing Base and Competitors
Table 16. Beijing Continent Major Business
Table 17. Beijing Continent Pirfenidone Product and Services
Table 18. Beijing Continent Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Cipla Basic Information, Manufacturing Base and Competitors
Table 20. Cipla Major Business
Table 21. Cipla Pirfenidone Product and Services
Table 22. Cipla Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Lupin Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Lupin Ltd Major Business
Table 25. Lupin Ltd Pirfenidone Product and Services
Table 26. Lupin Ltd Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 28. Zydus Cadila Major Business
Table 29. Zydus Cadila Pirfenidone Product and Services
Table 30. Zydus Cadila Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Glenmark Pharmaceuticals Major Business
Table 33. Glenmark Pharmaceuticals Pirfenidone Product and Services
Table 34. Glenmark Pharmaceuticals Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Koye Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Koye Pharmaceuticals Major Business
Table 37. Koye Pharmaceuticals Pirfenidone Product and Services
Table 38. Koye Pharmaceuticals Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 40. MSN Laboratories Major Business
Table 41. MSN Laboratories Pirfenidone Product and Services
Table 42. MSN Laboratories Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 44. Wockhardt Major Business
Table 45. Wockhardt Pirfenidone Product and Services
Table 46. Wockhardt Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Incepta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Incepta Pharmaceuticals Major Business
Table 49. Incepta Pharmaceuticals Pirfenidone Product and Services
Table 50. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Unimed Unihealth Basic Information, Manufacturing Base and Competitors
Table 52. Unimed Unihealth Major Business
Table 53. Unimed Unihealth Pirfenidone Product and Services
Table 54. Unimed Unihealth Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Pirfenidone Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 56. Global Pirfenidone Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Pirfenidone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Pirfenidone Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 59. Head Office and Pirfenidone Production Site of Key Manufacturer
Table 60. Global Pirfenidone Sales by Region (2016-2021e) & (K Pcs)
Table 61. Global Pirfenidone Sales by Region (2021-2026) & (K Pcs)
Table 62. Global Pirfenidone Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Pirfenidone Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Pirfenidone Sales by Type (2016-2021e) & (K Pcs)
Table 65. Global Pirfenidone Sales by Type (2021-2026) & (K Pcs)
Table 66. Global Pirfenidone Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Pirfenidone Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Pirfenidone Price by Type (2016-2021e) & (USD/Pcs)
Table 69. Global Pirfenidone Price by Type (2021-2026) & (USD/Pcs)
Table 70. Global Pirfenidone Sales by Application (2016-2021e) & (K Pcs)
Table 71. Global Pirfenidone Sales by Application (2021-2026) & (K Pcs)
Table 72. Global Pirfenidone Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Pirfenidone Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Pirfenidone Price by Application (2016-2021e) & (USD/Pcs)
Table 75. Global Pirfenidone Price by Application (2021-2026) & (USD/Pcs)
Table 76. North America Pirfenidone Sales by Country (2016-2021e) & (K Pcs)
Table 77. North America Pirfenidone Sales by Country (2021-2026) & (K Pcs)
Table 78. North America Pirfenidone Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Pirfenidone Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Pirfenidone Sales by Type (2016-2021e) & (K Pcs)
Table 81. North America Pirfenidone Sales by Type (2021-2026) & (K Pcs)
Table 82. North America Pirfenidone Sales by Application (2016-2021e) & (K Pcs)
Table 83. North America Pirfenidone Sales by Application (2021-2026) & (K Pcs)
Table 84. Europe Pirfenidone Sales by Country (2016-2021e) & (K Pcs)
Table 85. Europe Pirfenidone Sales by Country (2021-2026) & (K Pcs)
Table 86. Europe Pirfenidone Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Pirfenidone Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Pirfenidone Sales by Type (2016-2021e) & (K Pcs)
Table 89. Europe Pirfenidone Sales by Type (2021-2026) & (K Pcs)
Table 90. Europe Pirfenidone Sales by Application (2016-2021e) & (K Pcs)
Table 91. Europe Pirfenidone Sales by Application (2021-2026) & (K Pcs)
Table 92. Asia-Pacific Pirfenidone Sales by Region (2016-2021e) & (K Pcs)
Table 93. Asia-Pacific Pirfenidone Sales by Region (2021-2026) & (K Pcs)
Table 94. Asia-Pacific Pirfenidone Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Pirfenidone Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Pirfenidone Sales by Type (2016-2021e) & (K Pcs)
Table 97. Asia-Pacific Pirfenidone Sales by Type (2021-2026) & (K Pcs)
Table 98. Asia-Pacific Pirfenidone Sales by Application (2016-2021e) & (K Pcs)
Table 99. Asia-Pacific Pirfenidone Sales by Application (2021-2026) & (K Pcs)
Table 100. South America Pirfenidone Sales by Country (2016-2021e) & (K Pcs)
Table 101. South America Pirfenidone Sales by Country (2021-2026) & (K Pcs)
Table 102. South America Pirfenidone Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Pirfenidone Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Pirfenidone Sales by Type (2016-2021e) & (K Pcs)
Table 105. South America Pirfenidone Sales by Type (2021-2026) & (K Pcs)
Table 106. South America Pirfenidone Sales by Application (2016-2021e) & (K Pcs)
Table 107. South America Pirfenidone Sales by Application (2021-2026) & (K Pcs)
Table 108. Middle East & Africa Pirfenidone Sales by Country (2016-2021e) & (K Pcs)
Table 109. Middle East & Africa Pirfenidone Sales by Country (2021-2026) & (K Pcs)
Table 110. Middle East & Africa Pirfenidone Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Pirfenidone Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Pirfenidone Sales by Type (2016-2021e) & (K Pcs)
Table 113. Middle East & Africa Pirfenidone Sales by Type (2021-2026) & (K Pcs)
Table 114. Middle East & Africa Pirfenidone Sales by Application (2016-2021e) & (K Pcs)
Table 115. Middle East & Africa Pirfenidone Sales by Application (2021-2026) & (K Pcs)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Pirfenidone Typical Distributors
Table 119. Pirfenidone Typical Customers
List of Figures
Figure 1. Pirfenidone Picture
Figure 2. Global Pirfenidone Sales Market Share by Type in 2020
Figure 3. Tablet
Figure 4. Capsule
Figure 5. Other
Figure 6. Global Pirfenidone Sales Market Share by Application in 2020
Figure 7. Mild Idiopathic Pulmonary Fibrosis
Figure 8. Moderate Idiopathic Pulmonary Fibrosis
Figure 9. Other
Figure 10. Global Pirfenidone Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 11. Global Pirfenidone Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Pirfenidone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Pirfenidone Sales (2016-2026) & (K Pcs)
Figure 32. Global Pirfenidone Production Capacity (2016-2026) & (K Pcs)
Figure 33. Global Pirfenidone Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Pirfenidone Market Drivers
Figure 35. Pirfenidone Market Restraints
Figure 36. Pirfenidone Market Trends
Figure 37. Global Pirfenidone Sales Market Share by Manufacturer in 2020
Figure 38. Global Pirfenidone Revenue Market Share by Manufacturer in 2020
Figure 39. Pirfenidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Pirfenidone Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Pirfenidone Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Pirfenidone Sales Market Share by Region (2016-2026)
Figure 43. Global Pirfenidone Revenue Market Share by Region (2016-2026)
Figure 44. North America Pirfenidone Revenue (2016-2026) & (USD Million)
Figure 45. Europe Pirfenidone Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Pirfenidone Revenue (2016-2026) & (USD Million)
Figure 47. South America Pirfenidone Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Pirfenidone Revenue (2016-2026) & (USD Million)
Figure 49. Global Pirfenidone Sales Market Share by Type (2016-2026)
Figure 50. Global Pirfenidone Revenue Market Share by Type (2016-2026)
Figure 51. Global Pirfenidone Price by Type (2016-2026) & (USD/Pcs)
Figure 52. Global Pirfenidone Sales Market Share by Application (2016-2026)
Figure 53. Global Pirfenidone Revenue Market Share by Application (2016-2026)
Figure 54. Global Pirfenidone Price by Application (2016-2026) & (USD/Pcs)
Figure 55. North America Pirfenidone Sales Market Share by Country (2016-2026)
Figure 56. North America Pirfenidone Revenue Market Share by Country (2016-2026)
Figure 57. North America Pirfenidone Sales Market Share by Type (2016-2026)
Figure 58. North America Pirfenidone Sales Market Share by Application (2016-2026)
Figure 59. Europe Pirfenidone Sales Market Share by Country (2016-2026)
Figure 60. Europe Pirfenidone Revenue Market Share by Country (2016-2026)
Figure 61. Europe Pirfenidone Sales Market Share by Type (2016-2026)
Figure 62. Europe Pirfenidone Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Pirfenidone Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Pirfenidone Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Pirfenidone Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Pirfenidone Sales Market Share by Application (2016-2026)
Figure 67. South America Pirfenidone Sales Market Share by Country (2016-2026)
Figure 68. South America Pirfenidone Revenue Market Share by Country (2016-2026)
Figure 69. South America Pirfenidone Sales Market Share by Type (2016-2026)
Figure 70. South America Pirfenidone Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Pirfenidone Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Pirfenidone Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Pirfenidone Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Pirfenidone Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
特発性肺線維症の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen. Scope of the Report: This report studies the Idiopathic Pulmonary Fibrosis market stat…- 特発性血小板減少性紫斑病（ITP）治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 ITP (idiopathic thrombocytopenic purpura) is a rare disease with low affliction rates. This disease leads to excessive bruising or bleeding due to the lack of blood platelets. It is also known as immune thrombocytopenia and can affect children and adults alike. Scope of the Report: This report focus…
- 世界の眼線維症抗線維化療法市場 2021：企業別、地域別、種類・用途別 The Anti-Fibrotic Therapy for Ocular Fibrosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 慢性閉塞性肺疾患の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…
- 肺動脈カテーテルの世界市場2018-2025 This study researches the market size of Pulmonary Artery Catheter, presents the global Pulmonary Artery Catheter sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.This report focuses on the key data information of Pulmonary…